You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ABBV-951

Showing 51 - 75 of 121
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Crohn's Disease Trial in Worldwide (ABBV-154, Placebo)

Recruiting
  • Crohn's Disease
  • Dothan, Alabama
  • +185 more
Jan 27, 2023

Vanishing White Matter Disease Trial in Salt Lake City (ABBV-CLS-7262)

Recruiting
  • Vanishing White Matter Disease
  • Salt Lake City, Utah
    University of Utah Hospital
Mar 6, 2023

Relapsed/Refractory Multiple Myeloma Trial in Worldwide (ABBV-383, Dexamethasone, Lenalidomide)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Little Rock, Arkansas
  • +45 more
Jul 8, 2022

NSCLC, Head and Neck Squamous Cell Carcinoma Trial in Israel, Japan, United States (ABBV-514, Pembrolizumab, Budigalimab)

Recruiting
  • Non-Small Cell Lung Cancer
  • Head and Neck Squamous Cell Carcinoma
  • Fullerton, California
  • +13 more
Jul 11, 2022

DLBCL, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in New Haven, Worcester, Dallas (ABBV-319)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • +2 more
  • New Haven, Connecticut
  • +2 more
Aug 22, 2022

Systemic Lupus Erythematosus (SLE) Trial in Worldwide (Elsubrutinib, Placebo for Elsubrutinib, Upadacitinib)

Completed
  • Systemic Lupus Erythematosus (SLE)
  • Mesa, Arizona
  • +159 more
Dec 19, 2022

Advanced Solid Tumors Cancer Trial in Worldwide (Osimertinib, Nivolumab, Telisotuzumab vedotin)

Recruiting
  • Advanced Solid Tumors Cancer
  • Scottsdale, Arizona
  • +35 more
Jan 12, 2023

NSCLC, Advanced Solid Tumors, Gastroesophageal Adenocarcinoma Trial in Worldwide (ABBV-400)

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Santa Monica, California
  • +25 more
Jun 27, 2022

Parkinson's Disease Trial in Puerto Rico, United States (ABBV-0805, Placebo ABBV-0805)

Withdrawn
  • Parkinson's Disease
  • Gainesville, Florida
  • +5 more
Dec 13, 2021

Rheumatoid Arthritis (RA) Trial in Worldwide (ABBV-154, Placebo)

Active, not recruiting
  • Rheumatoid Arthritis (RA)
  • Phoenix, Arizona
  • +222 more
Jun 7, 2022

Postoperative Nausea and Vomiting (PONV) Trial in United States (TAK-951, Ondansetron, Ondansetron Placebo)

Completed
  • Postoperative Nausea and Vomiting (PONV)
  • Sheffield, Alabama
  • +6 more
Jul 21, 2022

Polymyalgia Rheumatica Trial in Worldwide (ABBV-154, Placebo, Glucocorticoid)

Recruiting
  • Polymyalgia Rheumatica
  • Jonesboro, Arkansas
  • +118 more
Aug 11, 2022

Ulcerative Colitis (UC) Trial in Worldwide (ABBV-323 Dose A, ABBV-323 Dose B)

Completed
  • Ulcerative Colitis (UC)
  • ABBV-323 Dose A
  • ABBV-323 Dose B
  • Tucson, Arizona
  • +33 more
Mar 10, 2022

CoronaVirus Disease-2019 (COVID-19) Trial in Worldwide (ABBV-47D11, Placebo for ABBV-47D11, ABBV-2B04)

Completed
  • CoronaVirus Disease-2019 (COVID-19)
  • Glendale, California
  • +17 more
Aug 30, 2021

Cholangiocarcinoma, Bile Duct Tumor, Biliary Tract Malignancy Trial run by the National Cancer Institute (NCI) (Tivozanib)

Recruiting
  • Cholangiocarcinoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 6, 2022

Rheumatoid Arthritis (RA) Trial in Worldwide (Elsubrutinib, Upadacitinib, Placebo for elsubrutinib)

Terminated
Has Results
  • Rheumatoid Arthritis (RA)
  • Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium
  • +29 more
Aug 18, 2021

Psoriasis Trial in Canada, Japan, United States (Cedirogant, Placebo)

Recruiting
  • Psoriasis
  • Birmingham, Alabama
  • +54 more
Aug 4, 2022

Alzheimer's Disease Trial in Worldwide (ABBV-8E12)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +56 more
Nov 15, 2021

Pancreatic Cancer Trial in Worldwide (ABBV-927, Budiglimab, modified FOLFIRINOX)

Recruiting
  • Pancreatic Cancer
  • Springdale, Arkansas
  • +23 more
May 23, 2022

Advanced Solid Tumors Trial in United States (paclitaxel, FOLFIRI, ABT-165)

Active, not recruiting
  • Advanced Solid Tumors
  • Scottsdale, Arizona
  • +9 more
Mar 23, 2022

Human Immuno-deficiency Virus (HIV) Disease Trial (Budigalimab, Placebo for Budigalimab, ABBV-382)

Not yet recruiting
  • Human Immuno-deficiency Virus (HIV) Disease
  • (no location specified)
Sep 5, 2023

Psoriasis Trial in United States (ABBV-157, Placebo for ABBV-157)

Completed
  • Psoriasis
  • Birmingham, Alabama
  • +9 more
May 7, 2021

Multiple Myeloma (MM), Cancer Trial in Worldwide (ABBV-467)

Terminated
  • Multiple Myeloma (MM)
  • Cancer
  • Tucson, Arizona
  • +23 more
Jul 20, 2021

Anemia of Chronic Kidney Disease Trial in Seoul (JTZ-951, Darbepoetin Alfa)

Completed
  • Anemia of Chronic Kidney Disease
  • Seoul, Korea, Republic of
    SMG-SNU Boramae Medical Center
Mar 19, 2021

Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC V7 Trial in Houston (ABBV-399)

Completed
Has Results
  • Recurrent Squamous Cell Lung Carcinoma
  • Stage IV Squamous Cell Lung Carcinoma AJCC V7
  • Houston, Texas
    M D Anderson Cancer Center
Sep 21, 2021